Prospects and Challenges of Translational Corneal Bioprinting
Corneal transplantation remains the ultimate treatment option for advanced stromal and endothelial disorders. Corneal tissue engineering has gained increasing interest in recent years, as it can bypass many complications of conventional corneal transplantation. The human cornea is an ideal organ for...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5354/7/3/71 |
id |
doaj-b11a8c08a7334de9991457bff8ad6a55 |
---|---|
record_format |
Article |
spelling |
doaj-b11a8c08a7334de9991457bff8ad6a552020-11-25T02:57:45ZengMDPI AGBioengineering2306-53542020-07-017717110.3390/bioengineering7030071Prospects and Challenges of Translational Corneal BioprintingMatthias Fuest0Gary Hin-Fai Yam1Jodhbir S. Mehta2Daniela F. Duarte Campos3Department of Ophthalmology, RWTH Aachen University, 52074 Aachen, GermanyDepartment of Ophthalmology, University of Pittsburgh, Pittsburgh, PA 15260, USATissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore 169856, SingaporeInstitute of Applied Medical Engineering, RWTH Aachen University, 52074 Aachen, GermanyCorneal transplantation remains the ultimate treatment option for advanced stromal and endothelial disorders. Corneal tissue engineering has gained increasing interest in recent years, as it can bypass many complications of conventional corneal transplantation. The human cornea is an ideal organ for tissue engineering, as it is avascular and immune-privileged. Mimicking the complex mechanical properties, the surface curvature, and stromal cytoarchitecure of the in vivo corneal tissue remains a great challenge for tissue engineering approaches. For this reason, automated biofabrication strategies, such as bioprinting, may offer additional spatial control during the manufacturing process to generate full-thickness cell-laden 3D corneal constructs. In this review, we discuss recent advances in bioprinting and biomaterials used for in vitro and ex vivo corneal tissue engineering, corneal cell-biomaterial interactions after bioprinting, and future directions of corneal bioprinting aiming at engineering a full-thickness human cornea in the lab.https://www.mdpi.com/2306-5354/7/3/71bioprintingcorneal tissue engineeringhydrogelcell-biomaterial interaction3D |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Matthias Fuest Gary Hin-Fai Yam Jodhbir S. Mehta Daniela F. Duarte Campos |
spellingShingle |
Matthias Fuest Gary Hin-Fai Yam Jodhbir S. Mehta Daniela F. Duarte Campos Prospects and Challenges of Translational Corneal Bioprinting Bioengineering bioprinting corneal tissue engineering hydrogel cell-biomaterial interaction 3D |
author_facet |
Matthias Fuest Gary Hin-Fai Yam Jodhbir S. Mehta Daniela F. Duarte Campos |
author_sort |
Matthias Fuest |
title |
Prospects and Challenges of Translational Corneal Bioprinting |
title_short |
Prospects and Challenges of Translational Corneal Bioprinting |
title_full |
Prospects and Challenges of Translational Corneal Bioprinting |
title_fullStr |
Prospects and Challenges of Translational Corneal Bioprinting |
title_full_unstemmed |
Prospects and Challenges of Translational Corneal Bioprinting |
title_sort |
prospects and challenges of translational corneal bioprinting |
publisher |
MDPI AG |
series |
Bioengineering |
issn |
2306-5354 |
publishDate |
2020-07-01 |
description |
Corneal transplantation remains the ultimate treatment option for advanced stromal and endothelial disorders. Corneal tissue engineering has gained increasing interest in recent years, as it can bypass many complications of conventional corneal transplantation. The human cornea is an ideal organ for tissue engineering, as it is avascular and immune-privileged. Mimicking the complex mechanical properties, the surface curvature, and stromal cytoarchitecure of the in vivo corneal tissue remains a great challenge for tissue engineering approaches. For this reason, automated biofabrication strategies, such as bioprinting, may offer additional spatial control during the manufacturing process to generate full-thickness cell-laden 3D corneal constructs. In this review, we discuss recent advances in bioprinting and biomaterials used for in vitro and ex vivo corneal tissue engineering, corneal cell-biomaterial interactions after bioprinting, and future directions of corneal bioprinting aiming at engineering a full-thickness human cornea in the lab. |
topic |
bioprinting corneal tissue engineering hydrogel cell-biomaterial interaction 3D |
url |
https://www.mdpi.com/2306-5354/7/3/71 |
work_keys_str_mv |
AT matthiasfuest prospectsandchallengesoftranslationalcornealbioprinting AT garyhinfaiyam prospectsandchallengesoftranslationalcornealbioprinting AT jodhbirsmehta prospectsandchallengesoftranslationalcornealbioprinting AT danielafduartecampos prospectsandchallengesoftranslationalcornealbioprinting |
_version_ |
1724709468017524736 |